調査レポートカテゴリー： MarketsandMarkets, 北米, 医療/バイオ

Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021

北米・欧州の静脈瘤治療市場予測：治療モード（静脈アブレーション、硬化療法、抜去）、製品（レーザー&RF焼灼、静脈閉鎖、手術製品）

◆タイトル：Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021
◆商品コード：MAM-MD-4294
◆調査・発行会社：MarketsandMarkets
◆発行日：2016年5月12日
◆ページ数：149
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：北米
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD5,650 ⇒換算￥0見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥0見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥0見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

本調査レポートでは、"北米・欧州の静脈瘤治療市場予測：治療モード（静脈アブレーション、硬化療法、抜去）、製品（レーザー&RF焼灼、静脈閉鎖、手術製品）"について調査・分析し、イントロダクション、エグゼクティブサマリー、市場の成長要因、阻害要因、市場の機会と課題、市場の動態、地域別分析、市場規模及び予測、競争状況、市場シェア分析、新製品発売、主要企業（ベンダー）分析等の情報をお届けいたします。

The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021. Shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, and huge burden of varicose vein cases in North America and Europe is driving the growth of the market. Other growth factors include improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population.
However, dearth of training for vascular surgeons, high cost of varicose vein treatment procedures, and implementation of healthcare reforms in the U.S. are some of the key factors restraining the growth of this market. In addition to this, challenges associated with inconsistent reimbursement scenario for varicose vein treatment procedures and sustainability of players in the highly competitive market also limits the growth of the market.

This report broadly segments the varicose vein treatment market into mode of treatment and products. On the basis of mode of treatment, the market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping. The endovenous ablation segment is expected to command the major share of the market, by mode of treatment, in 2016.

Based on type of products, the varicose vein treatment market is segmented into ablation devices, venous closure products, and surgical products. The ablation devices segment is further categorized into radiofrequency ablation devices and laser ablation devices. In 2016, the radiofrequency ablation devices segment is expected to command the major share of the ablation devices market for varicose vein treatment.

This report covers the varicose vein treatment market across two major geographies, namely, North America and Europe. In this report, the North American market is further segmented into the U.S. and Canada, while the European varicose vein treatment market is categorized into Germany, U.K., France, Italy, Spain, and Rest of Europe. In 2016, North America is expected to command the largest share of the market in North America and Europe. However, Europe is expected to register the highest growth rate during the forecast period from 2016 to 2021, due to increasing adoption of advanced treatment procedures and favorable government initiatives in this region.

Major players in the varicose vein treatment market include Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); biolitec AG (Austria); Syneron Medical Ltd. (Israel); Lumenis Ltd. (Israel); Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy); Vascular Solutions, Inc. (U.S.); Quanta System S.p.A. (Italy); Sciton, Inc. (U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.), among others

【レポートの目次】

1. Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study

2.Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation Models
2.3 Market Size Estimation Steps
2.4 Market Breakdown and Data Triangulation
2.5 Research Assumptions

3. Executive Summary
3.1 Introduction
3.2 Snapshot of Market in North America and Europe

4. Market Dynamics
4.1 Market Segmentation
4.2 Overview
4.3 Key Market Drivers
4.4 Key Market Restraints
4.5 Key Market Opportunities
4.6 Key Market Challenges

5. Varicose Vein Treatment Market in North America and Europe, By Treatment Mode
5.1 Introduction
5.2 Endovenous Ablation
5.3 Injection Sclerotherapy
5.4 Surgical Ligation/Stripping

6. Varicose Vein Treatment Market in North America and Europe, By Product
6.1 Introduction
6.2 Ablation Devices
6.2.1 Radiofrequency Ablation Devices
6.2.2 Laser Ablation Devices
6.3 Venous Closure Products
6.4 Surgical Products

7. Varicose Vein Treatment Market, By Region
7.1 Introduction
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 France
7.3.3 U.K.
7.3.4 Italy
7.3.5 Spain
7.3.6 Rest of Europe (RoE)

8. Competitive Landscape
8.1 Introduction
8.2 Market Share Analysis
8.3 Competitive Scenario
8.4 Recent Developments
8.4.1 New Product Launches
8.4.2 Acquisitions
8.4.3 Agreements
8.4.4 Other Developments

9. Company Profiles
9.1 Introduction
9.1.1 Geographic Benchmarking
9.2 Angiodynamics, Inc. (U.S.)
9.3 Medtronic, PLC (U.S.)
9.4 Biolitec Ag (Austria)
9.5 Syneron Medical Ltd. (Israel)
9.6 Lumenis Ltd. (Israel)

10. Appendix
10.1 Discussion Guide
10.2 Introducing RT: Real-Time Market Intelligence
10.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
10.4 Available Customizations
10.5 Related Reports

List of Tables (67 Tables)

Table - 1 Prevalence of Varicose Veins in the European Region
Table – 2 Prevalence of Primary Varicose Veins in European Region (2013) (Thousand)
Table – 3 Reimbursement Scenario for Varicose Vein Treatments in Europe, By Country
Table – 4 Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 5 Varicose Vein Treatment Modes Market Size, By Region, 2014–2021 (USD Million)
Table – 6 Varicose Vein Treatment Modes Market Size (USD Million) and Market Share (%), By Country, 2016
Table – 7 North America: Varicose Vein Treatment Modes Market Size, By Country, 2014–2021 (USD Million)
Table – 8 Europe: Varicose Vein Treatment Modes Market Size, By Country, 2014–2021 (USD Million)
Table – 9 Endovenous Ablation Market Size, By Region, 2014–2021 (USD Million)
Table – 10 North America: Endovenous Ablation Market Size, By Country, 2014–2021 (USD Million)
Table – 11 Europe: Endovenous Ablation Market Size, By Country, 2014–2021 (USD Million)
Table – 12 Injection Sclerotherapy Market Size, By Region, 2014–2021 (USD Million)
Table – 13 North America: Injection Sclerotherapy Market Size, By Country, 2014–2021 (USD Million)
Table – 14 Europe: Injection Sclerotherapy Market Size, By Country, 2014–2021 (USD Million)
Table – 15 Surgical Ligation/Stripping Market Size, By Region, 2014–2021 (USD Million)
Table – 16 North America: Surgical Ligation/Stripping Market Size, By Country, 2014–2021 (USD Million)
Table – 17 Europe: Surgical Ligation/Stripping Market Size, By Country, 2014–2021 (USD Million)
Table – 18 Market Size, By Product, 2014–2021 (USD Million)
Table – 19 Varicose Vein Treatment Product Market Size, By Region, 2014–2021 (USD Million)
Table – 20 North America: Varicose Vein Treatment Product Market Size, By Country, 2014–2021 (USD Million)
Table – 21 Europe: Varicose Vein Treatment Product Market Size, By Country, 2014–2021 (USD Million)
Table – 22 Varicose Vein Treatment Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table – 23 Ablation Devices Market Size, By Region, 2014–2021 (USD Million)
Table – 24 North America: Ablation Devices Market Size, By Country, 2014–2021 (USD Million)
Table – 25 Europe: Ablation Devices Market Size, By Country, 2014–2021 (USD Million)
Table – 26 Radiofrequency Ablation Devices Market Size, By Region, 2014–2021 (USD Million)
Table – 27 North America: Radiofrequency Ablation Devices Market Size, By Country 2014–2021 (USD Million)
Table – 28 Laser Ablation Devices Market Size, By Region, 2014–2021 (USD Million)
Table – 29 North American Venous Closure Products Market Size, By Country, 2014–2021 (USD Million)
Table – 30 North America: Laser Ablation Devices Market Size, By Country 2014–2021 (USD Million)
Table – 31 Europe: Laser Ablation Devices Market Size, By Country, 2014–2021 (USD Million)
Table – 32 Venous Closure Products Market Size, By Region, 2014–2021 (USD Million)
Table – 33 North America: Venous Closure Products Market Size, By Country, 2014–2021 (USD Million)
Table – 34 Europe: Venous Closure Products Market Size, By Country, 2014–2021 (USD Million)
Table – 35 Surgical Products Market Size, By Region, 2014–2021 (USD Million)
Table – 36 North America: Surgical Products Market Size, By Country, 2014–2021 (USD Million)
Table – 37 Europe: Surgical Products Market Size, By Country, 2014–2021 (USD Million)
Table – 38 Market Size, By Region, 2014-2021 (USD Million)
Table – 39 Market Size, By Country 2014-2021 (USD Million)
Table – 40 North America: Market Size, By Country and Treatment Mode, 2016 (USD Million)
Table – 41 North America: Market Size, By Country, 2014-2021 (USD Million)
Table – 42 North America: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table – 43 North America: Market Size, By Product, 2014-2021 (USD Million)
Table – 44 U.S.: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table – 45 U.S.: Market Size, By Product, 2014-2021 (USD Million)
Table – 46 Canada: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table – 47 Canada: Market Size, By Product, 2014-2021 (USD Million)
Table – 48 Europe: Market Size, By Country and Treatment Mode, 2016 (USD Million)
Table – 49 Europe: Market Size, By Country, 2014-2021 (USD Million)
Table – 50 Europe: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table – 51 Europe: Market Size, By Product, 2014-2021 (USD Million)
Table – 52 Germany: Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 53 Germany: Market Size, By Product, 2014–2021 (USD Million)
Table – 54 France: Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 55 France: Market Size, By Product, 2014–2021 (USD Million)
Table – 56 U.K.: Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 57 U.K.: Market Size, By Product, 2014–2021 (USD Million)
Table – 58 Italy: Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 59 Italy: Market Size, By Product, 2014–2021 (USD Million)
Table – 60 Spain: Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 61 Spain: Market Size, By Product, 2014–2021 (USD Million)
Table – 62 Rest of Europe: Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 63 Rest of Europe: Market Size, By Product, 2014–2021 (USD Million)
Table – 64 New Product Launches (2013–2016) (CNTD…)
Table – 65 Acquisitions (2013-2016)
Table – 66 Agreements (2013-2016)
Table – 67 Other Developments (2013-2016)

List of Figures (19 Figures)

Figure-1 Research Design
Figure-2 Breakdown of Primary Interviews: By Company Type, Designation, & Country
Figure-3 North American Varicose Vein Treatment Market, By Country: Market Share (2016) and CAGR (2016–2021)
Figure-4 European Market, By Country: Market Share (2016) and CAGR (2016–2021)
Figure-5 Healthcare Expenditures as Percentage of GDP in Major European Countries
Figure-6 Key Markets: Changing Proportion of Geriatric Individuals (Aged 65 Years and Above) in Total Population (2020 vs. 2030)
Figure-7 Market Share, By Product (2016–2021) (USD Million)
Figure-8 North America: Market, By Mode of Treatment, 2016 (%)
Figure-9 North America: Market Share, By Country (2016 vs. 2021)
Figure-10 North America: Market Share, By Mode of Treatment, 2016
Figure-11 Europe: Market, By Mode of Treatment, 2016 (USD Million)
Figure-12 Europe: Market Share, By Country (2016 vs. 2021)
Figure-13 EU-5: Market Share, By Mode of Treatment, 2016
Figure-14 Leading Market Players Adopted Product Development and Commercialization as Key Growth Strategies During 2012-2015
Figure-15 Market Share, By Key Player (2015)
Figure-16 Product Development, the Most Widely Adopted Growth Strategy During 2013-2016
Figure-17 Geographic Benchmarking
Figure-18 Marketsandmarkets Knowledge Store Snapshot
Figure-19 Marketsandmarkets Knowledge Store: Healthcare Industry Snapshot

【レポートのキーワード】

静脈瘤治療、治療モード、静脈アブレーション、硬化療法、抜去、レーザー、RF焼灼、静脈閉鎖、手術製品、北米、アメリカ、ヨーロッパ

★調査レポート[北米・欧州の静脈瘤治療市場予測：治療モード（静脈アブレーション、硬化療法、抜去）、製品（レーザー&RF焼灼、静脈閉鎖、手術製品）] ( Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021 / MAM-MD-4294) 販売に関する免責事項
[北米・欧州の静脈瘤治療市場予測：治療モード（静脈アブレーション、硬化療法、抜去）、製品（レーザー&RF焼灼、静脈閉鎖、手術製品）] ( Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021 / MAM-MD-4294) についてEメールでお問い合わせ

※関連データはありません。


◆H&Iグローバルリサーチ株式会社のお客様（例）◆